COVID-19

[P080] Oxytocin-augmented modular-based group intervention for loneliness: A randomized-controlled trial

*Rene Hurlemann¹, Ruben Berger², Simone Shamay-Tsoory³, Alisa Kanterman³, Maura Brausa², Jessica Gorni², Maike Luhmann⁴, Elisabeth Schramm⁵, Johannes Schultz⁶, Alexandra Philipsen², Jana Lieberz⁷, Dirk Scheele⁸ (1. Department of Psychiatry and Psychotherapy, School of Medicine and Health Sciences, University of Oldenburg, Oldenburg, Germany, 2. Department of Psychiatry and Psychotherapy, University Hospital Bonn, Bonn, Germany, 3. Department of Psychology, University of Haifa, Haifa, Israel, 4. Department of Psychological Methods, Faculty of Psychology, Ruhr-University Bochum, Bochum, Germany, 5. Department of Psychiatry and Psychotherapy, University of Freiburg Medical Center, University of Freiburg, Freiburg, Germany, 6. Center for Economics and Neuroscience, University of Bonn, Bonn, Germany, 7. Medical Psychology Section, Department of Psychiatry and Psychotherapy, University Hospital Bonn, Bonn, Germany, 8. Department of Medical Psychology and Medical Sociology, Faculty of Medicine, Ruhr-University Bochum, Bochum)

Keywords:Loneliness, Depression, Anxiety, Oxytocin, Psychotherapy